A Win For Madrigal Pharmaceuticals, Inc.

Mon, Dec 19, 2022 at 07:02 PM
A Win For Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc. (MDGL:NASDAQ) shot up at $234.83, representing a gain of 268.1%. On Mon, Dec 19, 2022, MDGL:NASDAQ hit a New 2-Week High of $234.83. The stock appeared on our News Catalysts scanner on Mon, Dec 19, 2022 at 04:45 PM in the 'MISCELLANEOUS' category. From Mon, Dec 05, 2022, the stock recorded 50.00% Up Days and 45.45% Green Days

About Madrigal Pharmaceuticals, Inc. (MDGL:NASDAQ)

Madrigal Pharmaceuticals Inc is a company focused on the development of novel compounds for the treatment of cardiovascular-metabolic diseases and nonalcoholic steatohepatitis (NASH).

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.